BRS2-FM1-PM3 - SAMe Synthesis
(Making the Body's Main Methyl Donor)
1. Mission & Overview
Mission
Convert methionine into SAMe so universal methyl-donation can power brain and body methylation chemistry.
Overview
Converts regenerated methionine into SAMe (S-adenosylmethionine, the body's universal methyl donor), the final step that turns recycled one-carbon capacity into usable methylation currency. Without sufficient SAMe output, downstream reactions spanning neurotransmitter synthesis, phospholipid formation, epigenetic regulation, and cellular repair cannot proceed at the rate the rest of the body demands. This step therefore converts upstream remethylation efficiency into system-wide methylation throughput.
- Converts methionine into SAMe, the body's universal methyl donor.
- Powers neurotransmitter, phospholipid, and epigenetic methylation reactions.
- Turns upstream remethylation efficiency into system-wide methylation output.
2. Primary Biological Effects
↑ methyl donor pool
3. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework. Biology → Phenome Confidence reflects how directly this mechanism's biology would be expected to affect the phenome within BRAIN architecture — not dietary treatment efficacy. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Medium
- Rationale: SAMe is the principal methyl donor linking methionine metabolism to phospholipid, neurotransmitter, and broader methylation chemistry — making methionine→SAMe flux a system-level bottleneck for cognitive-relevant methylation-dependent processes. Clinical framing of combined SAMe, folate, and B12 reinforces upstream cofactor dependency. Direct ADHD cognitive-clarity outcome trials on SAMe synthesis support remain limited (biology > evidence gap).
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Rationale: SAMe-dependent methylation intersects neurotransmitter and broader methylation chemistry relevant to affective regulation framing — an indirect framework translation from methyl-donor pool availability rather than direct emotional-regulation outcome measurement in ADHD populations.
- Key References:
- Evidence Confidence: Low
4. Levers
Intervention Profile
Intervention Dominance: Diet-Dominant
- Methionine ← eggs, meat, fish
- Folate ← leafy greens, legumes
- B12 ← shellfish, dairy, eggs
- Riboflavin (B2) ← dairy, eggs, lean meat
- Vitamin B6 ← poultry, fish, chickpeas
- Magnesium ← leafy greens, pumpkin seeds
- Magnesium ← leafy greens, pumpkin seeds
- Folate (B9) ← leafy greens, legumes
- Vitamin B12 ← shellfish, sardines, eggs
- Riboflavin (B2) ← dairy, eggs, lean meat
- Vitamin B6 ← poultry, fish, chickpeas
-
Methionine ← eggs, fish, poultry
-
Serine ← soy foods, eggs, turkey
-
Glycine ← gelatin-rich cuts, poultry, fish
-
Cysteine ← eggs, chicken, yogurt
1. Food Preparation & Delivery ONLY
- Consistent daily meal timing may support one-carbon and methyl-donor availability across the day.
- Gentle cooking of marine-fat sources helps limit oxidative degradation of PUFA-rich meal matrices — see Salmon — Preparation, Mackerel — Preparation.
- Soak and cook thoroughly to reduce phytates and improve mineral bioavailability; soaking and spro… — see Lentils — Preparation.
- Sleep and stress context may indirectly affect methylation demand; lifestyle factors are secondary to dietary substrate supply for this PM.
5. Mechanistic Basis
Summary
Universal methyl donation across the system depends on converting regenerated methionine to S-adenosylmethionine (SAMe) — the biochemical step that translates remethylation output into usable methyl-transfer capacity for downstream processes including neurotransmitter synthesis and phospholipid methylation.
(Methionine adenosyltransferase and SAMe formation)
Methionine adenosyltransferase converts methionine to SAMe in an ATP-dependent reaction. Magnesium supports this enzymatic step; without adequate methionine substrate from remethylation or dietary intake, SAMe production is constrained regardless of downstream methylation demand → [Chiang et al., 1996]
(Upstream remethylation dependency)
SAMe synthesis sits immediately downstream of homocysteine remethylation. Folate/B12-dependent remethylation (BRS2-FM1-PM1) and betaine/BHMT remethylation (BRS2-FM1-PM2) both feed methionine into this step. Folate, vitamin B12, riboflavin (B2), and vitamin B6 support the one-carbon steps that sustain methionine flux → [Chiang et al., 1996]; [Cicero and Minervino, 2022]
(Downstream methyl-transfer consumers)
SAMe is the universal methyl donor for phospholipid methylation (BRS2-FM3-PM7), neurotransmitter-relevant methylation chemistry within BRS1, and broader cellular methylation reactions. SAMe availability therefore couples one-carbon cycle efficiency to membrane and signalling biology across BRS domains.
(Boundaries of the mechanism)
This PM governs methionine→SAMe synthesis only.
Homocysteine remethylation routes belong to BRS2-FM1-PM1 and BRS2-FM1-PM2. Integrated cycle throughput belongs to BRS2-FM1-PM4.
Specific methyltransferase reactions — PEMT phospholipid methylation, neurotransmitter synthesis, DNA methylation — belong to their respective downstream PMs and BRS domains. This PM supplies the methyl donor pool; it does not govern individual transfer reactions.
(Integration within BRS2)
This PM bridges BRS2(FM1) — Methylation Cycle Efficiency and BRS2(FM3) — Methylation–Membrane Coupling. It depends on BRS2(KC2) — Methionine & Transsulfuration Substrate Pool for methionine substrate availability and on sibling remethylation PMs for sustained methionine regeneration.
5.1 Evidence Highlights
Introduction/Summary
SAMe biochemistry is well established. The studies below highlight why methyl-donor pool availability matters in clinical and translational contexts — particularly where combined cofactor support and downstream methylation demand shape interpretation.
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Review evidence positions SAMe as the principal methyl donor linking methionine metabolism to phospholipid, neurotransmitter, and broader methylation chemistry — making methionine→SAMe flux a system-level bottleneck rather than an isolated enzymatic detail → [Chiang et al., 1996]
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Clinical review work on combined SAMe, folate, and vitamin B12 support reinforces that SAMe availability is interpreted alongside upstream one-carbon cofactors rather than as an isolated supplement strategy → [Cicero and Minervino, 2022] This supports the PM3 placement: SAMe synthesis is downstream of remethylation cofactor coverage (PM1) and upstream of methylation-dependent processes across BRS2 and connected domains.
- Key References:
6. BRS Pathways and Connections
6.1 BRS Pathways
- None listed
6.2 Cross-BRS Mechanism Relationships
Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.
- BRS1-FM2-PM5 — Acetylcholine Synthesis Support — SAMe-dependent PEMT methylation
- BRS1-FM3-PM6 — Neuronal Membrane DHA Incorporation — Homocysteine disposal through transsulfuration toward cysteine
6.3 Local BRS Mechanism Relationships
Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.
- BRS2-FM1-PM1 - Folate/B12-Dependent Homocysteine Remethylation
- BRS2-FM1-PM2 - Betaine/BHMT Remethylation
- BRS2-FM1-PM4 - Methionine Cycle Flux
7. Scoreable Inputs & Modulation Signals
| Input Category | Example Inputs | PM relevance |
|---|---|---|
| Functional Property Potentials | methyl_donor_pattern; sulfur_amino_acid_context; choline_rich_food_matrix | May support same synthesis. |
| Realised Functional States | consistent_daily_methyl_donor_coverage | May reflect meal-level pathway support. |
| Preparation Transformations | minimally_processed; whole_food_matrix | May preserve nutrient density for pathway support. |